Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript
● Jun 1, 2022
Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur — Investor Relations Santhanam Subramanian — Chief...
